What United Therapeutics Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 815 | 2,772 |
| Total trades | 887 | 3,119 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 648,430 | 2,818,837 |
| Disposed | 648,528 | 2,872,045 |
| Net activity | −98 | −53,208 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −806 | $592.92 | −$478K | 324,443 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −694 | $591.60 | −$411K | 325,249 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −680 | $590.57 | −$402K | 325,943 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −1,280 | $589.64 | −$755K | 326,623 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −1,241 | $588.47 | −$730K | 327,903 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −2,707 | $587.54 | −$1.59M | 329,144 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −1,492 | $586.54 | −$875K | 331,851 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Open-market sale · S | −600 | $585.71 | −$351K | 333,343 |
| Rothblatt Martine A | Chairperson & CEO | Oct 26 | Exercise / conversion · M | +9,500 | $117.76 | +$1.12M | 333,943 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −740 | $588.00 | −$435K | 324,443 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −542 | $586.93 | −$318K | 325,183 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −778 | $585.99 | −$456K | 325,725 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −676 | $584.77 | −$395K | 326,503 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −427 | $583.83 | −$249K | 327,179 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −1,732 | $582.78 | −$1.01M | 327,606 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −1,650 | $581.82 | −$960K | 329,338 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −1,017 | $580.78 | −$591K | 330,988 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −1,038 | $579.74 | −$602K | 332,005 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −700 | $578.80 | −$405K | 333,043 |
| Rothblatt Martine A | Chairperson & CEO | Oct 23 | Open-market sale · S | −200 | $577.68 | −$116K | 333,743 |
Loading...
